1. Academic Validation
  2. Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5

Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5

  • Nat Cell Biol. 2006 May;8(5):435-45. doi: 10.1038/ncb1395.
Hassan Mziaut 1 Mirko Trajkovski Stephan Kersting Armin Ehninger Anke Altkrüger Régis P Lemaitre Darja Schmidt Hans-Detlev Saeger Myung-Shik Lee David N Drechsel Stefan Müller Michele Solimena
Affiliations

Affiliation

  • 1 Experimental Diabetology, School of Medicine, Dresden University of Technology, Dresden 01307, Germany.
Abstract

Nutrients and growth Hormones promote Insulin production and the proliferation of pancreatic beta-cells. An imbalance between ever-increasing metabolic demands and Insulin output causes diabetes. Recent evidence indicates that beta-cells enhance Insulin gene expression depending on their secretory activity. This signalling pathway involves a catalytically inactive Receptor Tyrosine Phosphatase, ICA512, whose cytoplasmic tail is cleaved on glucose-stimulated exocytosis of Insulin secretory granules and then moves into the nucleus, where it upregulates Insulin transcription. Here, we show that the cleaved cytosolic fragment of ICA512 enhances the transcription of secretory granule genes (including its own gene) by binding to tyrosine phosphorylated signal transducers and activators of transcription (STAT) 5 and preventing its dephosphorylation. Sumoylation of ICA512 by the E3 SUMO ligase PIASy, in turn, may reverse this process by decreasing the binding of ICA512 to STAT5. These findings illustrate how the exocytosis of secretory granules, through a retrograde pathway that sustains STAT activity, converges with growth hormone signalling to induce adaptive changes in beta-cells in response to metabolic demands.

Figures